Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zhaoke Ophthalmology Ltd. ( (HK:6622) ) just unveiled an update.
Zhaoke Ophthalmology Limited has announced its upcoming annual general meeting, scheduled for May 16, 2025, where shareholders will vote on resolutions to authorize the company’s directors to repurchase shares and issue additional shares or securities. These resolutions, if passed, will enable the company to manage its share capital more flexibly, potentially impacting its market positioning and shareholder value.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Limited is a company incorporated in the British Virgin Islands and continued in the Cayman Islands. It operates within the ophthalmology industry, focusing on developing and commercializing treatments for eye diseases. The company is listed on the Stock Exchange of Hong Kong.
YTD Price Performance: 38.33%
Average Trading Volume: 2,676,931
Technical Sentiment Signal: Buy
Current Market Cap: HK$846.5M
Learn more about 6622 stock on TipRanks’ Stock Analysis page.